Collegium Pharmaceutical Inc (COLL)
Debt-to-assets ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total assets | US$ in thousands | 1,663,590 | 1,635,150 | 1,053,390 | 1,114,250 | 1,143,310 | 1,177,580 | 1,213,910 | 1,214,300 | 1,174,130 | 1,200,940 | 1,245,570 | 1,246,140 | 692,077 | 741,803 | 713,735 | 646,065 | 643,841 | 643,843 | 646,870 | 634,793 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,663,590K
= 0.00
Collegium Pharmaceutical Inc has consistently maintained a debt-to-assets ratio of 0.00 from March 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt to finance its assets during this period. A debt-to-assets ratio of 0.00 implies that the company's assets are entirely financed by equity, which can be seen as a positive sign of financial stability and strength. It suggests that Collegium Pharmaceutical Inc has a solid financial position with a low level of financial risk associated with debt. Overall, the company's consistent low debt-to-assets ratio reflects a healthy balance sheet structure and prudent financial management.
Peer comparison
Dec 31, 2024